Russia Forms JV With U.S. Biotechs Selecta, BIND
This article was originally published in PharmAsia News
Executive Summary
Russia’s state-formed Rusnano has formed an alliance with two U.S. biotechs, Selecta Biosciences and BIND Biosceinces, to discover and develop innovative drugs, with the Russian firm having a majority interest.